Open Access
Med Buccale Chir Buccale
Volume 16, Number 3, juillet 2010
Page(s) 183 - 188
Section Observations cliniques / Case reports
Published online 12 July 2010
  1. Figueroa-Pazos E, Kimura-Fujikami K, Criales-C JL. Plasmocytoma: a case report. Gac Med Mex 2005;141:335-37. [PubMed]
  2. Lewanski CR, Bates T, Bowen J, Ashford RF. Solitary Bone plasmacytoma: management of isolated local relapse following radiotherapy. Clin Oncol 1999;11:348-51. [CrossRef] [PubMed]
  3. Stoopler ET, Vogl DT, Stadtmauer EA. Medical management update: multiple myeloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:599-609. [CrossRef] [PubMed]
  4. Mozaffari E, Mupparapu M, Otis L. Undiagnosed multiple myeloma causing extensive dental bleeding: report case and review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:448-53. [CrossRef] [PubMed]
  5. Lee SH, Huang JJ, Pan WL, Chan CP. Gingival mass as the primary manifestation of multiple myeloma: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:75–9. [CrossRef] [PubMed]
  6. Feller L, White J, Wood NH, Bouckaert M, Lemmer J, Raubenheimer EJ. Extramedullary myeloma in an HIV-seropositive subject. Literature review and report of an unusual case. Head Face Med 2009;5:4. [CrossRef] [PubMed]
  7. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed. IARC Press, Lyon, 2008.
  8. Owotade F, Ugboko V, Ajike S, Salawu L, Amusa Y, Omole M. Head and neck manifestations of myeloma in Nigerians. Int J Oral Maxillofac Surg 2005;34:761-5. [CrossRef] [PubMed]
  9. Witt C, Borges AC, Klein K, Neumann HJ. Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients. J Oral Maxillofac Surg 1997;55:450-3. [CrossRef] [PubMed]
  10. Kurabayashi H, Kubota K, Murakami H, Tamura J, Sawamura M, Nogiwa E, Shinonome S, Miyawaki S, Sato S, Omine M, Naruse T, Shirakura T, Tsuchiya J. Ultrastructure of myeloma cells in patients with common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma. Cancer Res 1988;48:6234-7. [PubMed]
  11. Lae ME, Ventio EF, Inwards CY, Unni KK, Nascimento AG. Myeloma of the jaw bones: a clinicopathologic study of 33 cases. Head Neck 2003;25:373-81. [CrossRef] [PubMed]
  12. Sukpanichnant S, Cousar JB, Leelasiri A, Graber SE, Greer JP, Collins RD. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation. Hum Pathol 1994;25:308-18. [CrossRef] [PubMed]
  13. Greipp PR, Raymond NM, Kyle RA, O’Fallon WM. Multiple myeloma: significance of plasmablastic subtype in morpholo-gical classification. Blood 1985;65:305-10. [PubMed]
  14. American Cancer Society. Cancer facts and figures 2006. Atlanta (GA): American Cancer Society; 2006. Available on:
  15. Durie BGM, Salomon SE. A clinical staging system for multiple myeloma. Cancer 1975;36:842-54. [CrossRef] [PubMed]
  16. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-20. [CrossRef] [PubMed]
  17. Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol 2008;144:86-94. [CrossRef] [PubMed]
  18. Epstein JB, Voss NJ, Stevenson-Moore P. Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature. Oral Surg Oral Med Oral Pathol 1984;57:267-71. [CrossRef] [PubMed]
  19. Pisano JJ, Coupland R, Chen SY, Miller AS. Plasmacytoma of the oral cavity and jaws: a clinicopathologic study of 13 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:265-71. [CrossRef] [PubMed]
  20. Anacak Y, Kamer S, Donmez A, Haydaroglu A. Destruction of molar roots by metastasis of multiple myeloma. Br J Oral Maxillofac Surg 2002;40:515. [CrossRef] [PubMed]
  21. Lee SH, Huang JJ, Pan WL, Chan CP. Gingival mass as the primary manifestation of multiple myeloma: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:75-9. [CrossRef] [PubMed]
  22. Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Natl Med J India 2003;16:16-21. [PubMed]
  23. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma, J Clin Oncol 1999;17:1551-7. [PubMed]
  24. Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, Finch CJ, Vilchez RA, McGregor D, Jorgensen JL. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Modern Pathol 2005;18:806-15. [CrossRef]
  25. Denz U, Haas PS, Wäsch R, Einsele H, Engelhardt M. State of the art therapy in multiple myeloma and future perspectives. Eur J Cancer 2006;42:1591-600. [CrossRef] [PubMed]
  26. Tirado-Gómez LL, Mohar Betancourt A. Epidemiologia de las neoplasias hemato-oncológicas, INCan, Mexico, 2007.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.